Ligand Pharmaceuticals In shares owned by Smith, Graham & Co. Investment Advisors
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Smith, Graham & Co. Investment Advisors
from 13F filings
Historical chart of Smith, Graham & Co. Investment Advisors investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by Smith, Graham & Co. Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by Smith, Graham & Co. Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.9M | 83k | 71.42 |
| 2023-09-30 | $3.7M | 62k | 59.92 |
| 2023-06-30 | $4.5M | 62k | 72.10 |
| 2023-03-31 | $4.8M | 65k | 73.56 |
| 2022-12-31 | $4.4M | 65k | 66.80 |
| 2022-09-30 | $7.4M | 86k | 86.11 |
| 2022-06-30 | $7.7M | 86k | 89.22 |
| 2022-03-31 | $9.8M | 87k | 112.49 |
| 2021-12-31 | $14M | 87k | 154.46 |
| 2021-09-30 | $13M | 94k | 139.32 |
| 2021-06-30 | $13M | 98k | 131.19 |
| 2021-03-31 | $16M | 102k | 152.45 |
| 2020-12-31 | $9.7M | 98k | 99.45 |
| 2020-09-30 | $7.0M | 74k | 95.32 |
More positions owned by Smith, Graham & Co. Investment Advisors
View all positions for Smith, Graham & Co. Investment Advisors